NuVasive

NUVASIVE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NuVasive, Inc. - NUVA

Retrieved on: 
Wednesday, March 29, 2023

and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NuVasive, Inc. (NasdaqGS: NUVA) to Globus Medical, Inc. (NYSE: GMED).

Key Points: 
  • and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NuVasive, Inc. (NasdaqGS: NUVA) to Globus Medical, Inc. (NYSE: GMED).
  • Under the terms of the proposed transaction, shareholders of NuVasive will receive 0.75 of a share of Globus Medical Class A common stock for each share of NuVasive that they own.
  • KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
  • To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GMED, ARGO, OSH

Retrieved on: 
Sunday, March 26, 2023

If you are a Globus shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Globus shareholder, click here to learn more about your rights and options .
  • If you are an Argo shareholder, click here to learn more about your rights and options .
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PTRS, FOCS, ROCC, NUVA

Retrieved on: 
Friday, March 24, 2023

If you are a Partners shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Partners shareholder, click here to learn more about your rights and options .
  • Focus Financial Partners Inc. (NASDAQ: FOCS)’s sale to affiliates of Clayton, Dubilier & Rice, LLC for $53.00 per share in cash.
  • If you are a Focus shareholder, click here to learn more about your rights and options .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

STOCKHOLDER ALERT: The M&A Class Action Firm Continues its Investigation of the Merger – NUVA, ANGN, AGFS, CSII

Retrieved on: 
Wednesday, March 22, 2023

Under the terms of the agreement, NUVA shareholders are expected to receive 0.75 shares of Globus per share they own.

Key Points: 
  • Under the terms of the agreement, NUVA shareholders are expected to receive 0.75 shares of Globus per share they own.
  • Angion Biomedica Corp. (NASDAQ: ANGN ), relating to its proposed merger with Elicio Therapeutics.
  • Under the terms of the agreement, AGFS shareholders are expected to receive $3.00 in cash per share they own.
  • Under the terms of the agreement, CSII shareholders are expected to receive $20.00 in cash per common share they own.

CNEXT Focuses on Inclusivity and Advancing High-Potential Leaders

Retrieved on: 
Tuesday, March 21, 2023

A recent survey shows 35 percent of HR leaders say diversity, equity, and inclusion are among their top five priorities.

Key Points: 
  • A recent survey shows 35 percent of HR leaders say diversity, equity, and inclusion are among their top five priorities.
  • The 18-month program is a holistic approach to development and learning that prepares emerging leaders for continued corporate advancement while also developing the leaders who manage them - helping to accelerate diverse leaders through the pipeline to senior leadership.
  • "We realize there are other leadership development programs, but CNEXT is and always has been committed to developing an exceptionally diverse and inclusive community of leaders," says Cheryl Stokes , CEO of CNEXT.
  • "The CNEXT Movement focuses on cultivating inclusion and delivering exponential results for next-level leaders.

NuVasive Specialized Orthopedics Expands Indications of Precice Limb Lengthening System to Treat Pediatric Patients

Retrieved on: 
Monday, March 20, 2023

The expanded clearance extends the clinical benefits of Precice to a wider range of patients.

Key Points: 
  • The expanded clearance extends the clinical benefits of Precice to a wider range of patients.
  • "Everyone faced with limb length discrepancy (LLD), especially pediatric patients, should have access to a non-invasive limb lengthening solution," said Pete Ligotti, leader of NuVasive Specialized Orthopedics (NSO).
  • As a division of NuVasive, NSO is focused on the design and innovation of disruptive orthopedic solutions for complex orthopedic reconstruction and limb lengthening.
  • "Precice has over a decade's worth of clinical data and has truly changed the standard of care for my patients," said Dr. John Herzenberg, director of pediatric orthopedics at Sinai Hospital.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FOCS, GMED, ARGO, OSH

Retrieved on: 
Sunday, March 19, 2023

If you are a Focus shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Focus shareholder, click here to learn more about your rights and options .
  • If you are a Globus shareholder, click here to learn more about your rights and options .
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

Orthopedic Devices Market worth $48.1 billion | MarketsandMarkets

Retrieved on: 
Thursday, March 16, 2023

The Asia Pacific orthopedic devices market is projected to grow at the highest CAGR of 5.8% from 2022 to 2028.

Key Points: 
  • The Asia Pacific orthopedic devices market is projected to grow at the highest CAGR of 5.8% from 2022 to 2028.
  • In September 2022, Stryker Corporation introduced New Gamma4 Hip fracture nailing system to expand its orthopedic fixation devices product portfolio.
  • Orthopedic devices help to alleviate pain and improve the quality of life for patients suffering from various orthopedic conditions.
  • Orthopedic devices are minimally invasive, making them easy to use and less risky than traditional treatments.

Orthopedic Devices Market worth $48.1 billion | MarketsandMarkets

Retrieved on: 
Thursday, March 16, 2023

The Asia Pacific orthopedic devices market is projected to grow at the highest CAGR of 5.8% from 2022 to 2028.

Key Points: 
  • The Asia Pacific orthopedic devices market is projected to grow at the highest CAGR of 5.8% from 2022 to 2028.
  • In September 2022, Stryker Corporation introduced New Gamma4 Hip fracture nailing system to expand its orthopedic fixation devices product portfolio.
  • Orthopedic devices help to alleviate pain and improve the quality of life for patients suffering from various orthopedic conditions.
  • Orthopedic devices are minimally invasive, making them easy to use and less risky than traditional treatments.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANGN, CSII, NUVA

Retrieved on: 
Thursday, March 16, 2023

If you are an Angion shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are an Angion shareholder, click here to learn more about your rights and options .
  • If you are a Cardiovascular shareholder, click here to learn more about your rights and options .
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.